Edition:
United Kingdom

Zur Rose Group Expects Sales Of CHF 1.6 Billion In 2019


Thursday, 21 Mar 2019 

March 21 (Reuters) - Zur Rose Group AG ::FY REVENUE OF CHF 1,207.1 MILLION SIGNIFICANTLY EXCEEDED BILLION SWISS FRANC THRESHOLD AND GREW BY 22.8 PER CENT.FY EBITDA WAS MINUS CHF 12.5 MILLION; NET INCOME / (LOSS) WAS MINUS CHF 39.1 MILLION.COMPANY AIMS TO DOUBLE ITS 2018 SALES BY 2022.EBITDA TARGET MARGIN FOR 2022 IS 5 TO 6 PERCENT, CORRESPONDING TO CHF 120 MILLION TO CHF 150 MILLION.OUTLOOK 2019: EXPECTS SALES OF CHF 1.6 BILLION (INCLUDING MEDPEX'S TOTAL ANNUAL SALES).OUTLOOK 2019: FOCUS REMAINS ON GROWTH, WITH AIM OF ACHIEVING BREAK-EVEN AT EBITDA LEVEL.